Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antibiotic Research Stalling In Conversion Of Target Into New Drug

Executive Summary

Translating validated targets into clinical candidates is the major hurdle in discovering new antibiotics to combat resistance, Lilly VP-Scientific Affairs Gail Cassell, PhD, suggested in a presentation to FDA's Center for Drug Evaluation & Research Jan. 7

You may also be interested in...



Antibiotics Should Be One Step On FDA’s “Critical Path,” Lilly VP Says

Antibiotic development is an ideal FDA "Critical Path" opportunity due to the lack of antitrust concerns surrounding the therapeutic category, Lilly VP-Scientific Affairs Gail Cassell, PhD, told the FDA Science Board Advisory Committee April 22

Antibiotics Should Be One Step On FDA’s “Critical Path,” Lilly VP Says

Antibiotic development is an ideal FDA "Critical Path" opportunity due to the lack of antitrust concerns surrounding the therapeutic category, Lilly VP-Scientific Affairs Gail Cassell, PhD, told the FDA Science Board Advisory Committee April 22

Antibiotic Trial Without Comparator Would Lower R&D Cost, Wyeth Exec Says

Antibiotic trials without comparator drug arms would lower development costs, Wyeth Antibacterial Research Director Steven Projan, PhD, suggested

Related Content

UsernamePublicRestriction

Register

PS043159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel